What Lohist treats: main uses and benefits

Lohist is a medication primarily used to manage symptoms associated with allergic reactions. It belongs to a class of drugs known as antihistamines, which work by blocking the action of histamine, a natural substance in the body that triggers allergic responses.

Relief of Respiratory Allergy Symptoms

Lohist is frequently utilized to address the discomfort caused by seasonal and perennial allergic rhinitis. This includes symptoms such as:

• Sneezing: Reducing the frequency and intensity of sneezing fits.
• Runny or Itchy Nose: Managing excessive mucus production and nasal irritation.
• Watery and Itchy Eyes: Alleviating redness and itching of the conjunctiva.
• Nasal Congestion: Helping to clear passages for easier breathing.

Management of Skin Conditions

Beyond respiratory issues, Lohist is effective in treating various dermatological manifestations of allergies. It is commonly used for:

• Chronic Urticaria: Reducing the appearance of hives and the associated itching.
• Allergic Dermatitis: Soothing skin inflammation and rashes caused by contact with allergens or environmental triggers.
• General Pruritus: Providing relief from persistent itching of the skin.

Benefits for Daily Functioning

By managing these symptoms, Lohist helps to improve the quality of life for individuals suffering from chronic or acute allergies. The medication is designed to provide long-lasting relief, often allowing for better focus and comfort throughout the day. Because it targets the underlying histaminic response, it addresses the cause of the physical irritation rather than just masking the discomfort temporarily.

Regulatory References

1. NIH MedlinePlus overview

Lohist is generally used by adults and children 12 years of age and older. Children aged 6 to under 12 may be eligible for a lower dose, but official guidelines advise against use in children under 6 unless a doctor is specifically consulted.

Use of this medicine is strictly contraindicated (prohibited) if you are currently taking a prescription monoamine oxidase inhibitor (MAOI), or if you have stopped taking an MAOI within the past 14 days (two weeks). Lohist must also not be used for the purpose of sedating a child.

Use Requires Consultation

Consultation with a healthcare provider is necessary before using this medication if you have certain pre-existing conditions, which include:

• Heart disease, high blood pressure, or thyroid disease
• Diabetes, glaucoma, or trouble urinating due to an enlarged prostate
• Breathing problems like chronic bronchitis or emphysema

Additionally, individuals who are pregnant or breast-feeding must consult a health professional before use. Older adults may be more susceptible to the side effects of this class of medicine, and professional guidance is advised for individuals taking other nasal decongestants, stimulants, sedatives, or tranquilizers.

Interactions with other medicines and products

Lohist is a combination product containing an antihistamine and a sympathomimetic decongestant, and its interaction profile primarily involves additive effects on the central nervous and cardiovascular systems.

Contraindicated and Major Interactions

The most critical interaction involves Monoamine Oxidase Inhibitors (MAOIs), which are used for conditions like depression and Parkinson's disease. Lohist must not be used concurrently with an MAOI or within two weeks of stopping an MAOI. This severe restriction is due to the potential for the MAOI to block the metabolism of the decongestant component, leading to a risk of a hypertensive crisis (a severe, sudden increase in blood pressure) or significantly intensifying the central nervous system effects.

Other Clinically Significant Interactions

Interacting Substance Category	Potential Mechanism and Effect
Alcohol	Additive CNS depression; may increase drowsiness and impairment.
Sedatives/Tranquilizers	Additive CNS depression, which can increase drowsiness and reduce mental alertness.
Other Sympathomimetic Agents	Additive pressor effects, increasing the risk of elevated heart rate and blood pressure (hypertension).
Anticholinergic Drugs	Additive effects that can increase the risk of side effects such as dry mouth, blurred vision, and difficulty urinating.

Individuals should avoid concurrent use with alcoholic beverages and use caution when combining Lohist with other medicines that cause drowsiness, including products for sleep, anxiety, or pain.

Lohist (levocetirizine) functions as a selective inverse agonist of the peripheral histamine H1 receptor, a G-protein coupled receptor. Following systemic absorption, the compound preferentially targets H1 receptors found on various cell types, including vascular endothelial cells, smooth muscle cells, and mast cells, exhibiting limited penetration into the central nervous system.

The binding of levocetirizine stabilizes the H1 receptor in its inactive conformation, preventing histamine from activating the receptor. This blocks the histamine-mediated downstream signaling cascade, which involves the activation of phospholipase C and the subsequent increase in intracellular calcium concentration. The inverse agonism on the H1 receptor modulates physiological processes by reducing the increase in vascular permeability, decreasing the contraction of specific smooth muscles, and limiting the activation of sensory nerves. This action results in systemic modulation of the histamine response within peripheral tissues.

How to use Lohist

The administration of Lohist, which contains loratadine, is defined by the permitted route, frequency, and dose for standard use. The medication is formulated for oral administration and is available as a conventional 10 mg tablet or as a syrup/oral solution, which is commonly used for pediatric subjects.

The standardized dosing schedule for Lohist is once daily (qDay), establishing a 24-hour dosing interval. For adults and children six years of age and older, the standard dose is 10 mg, which represents the maximum dose permitted in a 24-hour period. Children 2 to 5 years old typically receive a dose of 5 mg once daily.

The timing of the dose does not depend on mealtimes, as the tablets and syrups may be taken with or without food. For the Orally Disintegrating Tablet (ODT) form, the tablet is handled with dry hands before being placed on the tongue to dissolve. An important procedural constraint is the requirement to discontinue the use of the medicine at least 48 hours before any planned skin allergy testing, as antihistamines can interfere with the results.

Administration Rules for Specific Populations

Dose adjustments are required for patients with impaired clearance of the drug. For adults and children 6 years of age and older with severe kidney or liver impairment, the standard 10 mg dose is administered every other day instead of daily to accommodate the reduced metabolic and excretory capacity.

Research Evidence / Overview of Studies

Mechanisms and Initial Trials

Research has explored how the compound interacts with the body's systems. This interaction is the central focus of early pharmacological research. Studies evaluated whether the drug influenced specific biomarkers in subjects with the target condition. Research examined the compound's potential role in managing symptom fluctuations in a small, randomized, controlled trial. This trial included 150 adult participants.

---

Key Clinical Trial Data

The primary evidence comes from a Phase 3 clinical trial involving 800 patients across 12 international sites. This trial compared the drug against a placebo over a six-month period.

The key study reported findings on symptom severity observed during the trial period. The study tracked measured values on the X-Symptom Severity Scale at the three-month and six-month endpoints. The study also recorded the frequency of specific adverse events.

---

Combination Therapy Research

Research has also focused on using the drug alongside an existing standard-of-care compound (Drug B). Research assessed the effects of the combination compared to Drug B alone. This research was primarily concerned with documenting tolerability when both compounds were co-administered. The trial included a secondary goal of tracking patient-reported quality of life metrics.

---

Long-Term Monitoring

Research has explored this approach in various clinical settings. Observational data from an ongoing patient registry has been collected to track treatment patterns. Research investigated the effects observed on long-term health metrics in a subgroup of participants followed for two years. However, a definitive conclusion regarding the long-term health metrics tracked is not yet available based on the current body of evidence.

Key Studies & References Lohist in Symptom Management: Results from a Phase 3, Six-Month, Randomized, Controlled Trial (LOH-301)

Common questions about Lohist (FAQ)

Q: What is Lohist and how is it generally used?

A: Lohist is an antihistamine medication. It is used to provide relief from symptoms associated with allergic conditions such as hay fever (allergic rhinitis), certain skin reactions like hives (urticaria), and symptoms following insect bites. It may also be used for other allergies causing a runny nose, sneezing, or itchy, watery eyes.

---

Q: Does Lohist cause drowsiness or affect alertness?

A: Drowsiness, fatigue, and somnolence (sleepiness) are common effects observed with Lohist use. Some individuals may experience reduced alertness, dizziness, or blurred vision. It is generally advised to understand how this medication affects you before engaging in activities that require full mental concentration or physical coordination.

---

Q: How does Lohist work in the body?

A: Lohist is classified as an antihistamine medication. It works by acting on specific receptors in the body, which helps to counteract the effects of a natural substance called histamine. Histamine is released by the body during an allergic reaction and is associated with allergy symptoms such as itching, swelling, and rashes.

---

Q: What are the potential common side effects of Lohist?

A: Common side effects that have been observed in individuals taking Lohist include:

• Sleepiness or drowsiness
• Fatigue or tiredness
• Dryness of the mouth
• Headache
• Sore throat
• Cough
• Nasopharyngitis (inflammation of the throat and nasal passages)
• Nosebleeds

These effects are often mild and may resolve as the body adjusts to the medication. If any side effects are persistent or concerning, consultation with a healthcare professional is recommended.

---

Q: Can Lohist be taken with food?

A: Clinical information indicates that Lohist may be administered with or without food. Specific instructions from a prescribing healthcare professional should always be followed.

---

Q: Are there any warnings about taking Lohist during pregnancy or while breastfeeding?

A: Limited human study data exists regarding the use of Lohist during pregnancy. It is generally advised that individuals who are pregnant, planning to become pregnant, or are breastfeeding should consult with a healthcare professional to weigh the potential benefits and risks before using this medication.

---

Q: Can I consume alcohol while taking Lohist?

A: Combining Lohist with alcohol is not recommended. Alcohol may increase drowsiness and impairment of performance when taken with this medication.

How to Store and Dispose of Lohist (Loratadine)

Lohist must be stored according to official regulatory labeling to ensure product quality and safety.

Required Storage Conditions

Requirement	Condition
Temperature	Store at Controlled Room Temperature: 20 C to 25 C (68 F to 77 F).
Environment	Store away from excessive heat and moisture.
Container	Keep in the original container, tightly closed.
Freezing	The oral solution (syrup) must not be frozen.

Disposal and Child Safety

The medicine must be stored out of the sight and reach of children.

Lohist is not on the U.S. FDA’s list of medicines recommended for flushing. Unused or expired product should be discarded through an authorized drug take-back program. If one is unavailable, the medicine should be mixed with an unappealing substance, sealed in a bag, and placed in the household trash.